We statistically compared the 335 CIS-associated autoantigens (Figure 3C) between each MS subgroup (PBO-A, PBO-NA, RNF-A, RNF-NA) and HCs at baseline. This evidence concerns the gene TRIM31 and in situ carcinoma.